Literature DB >> 2488098

Nitrate tolerance in angina pectoris.

J O Parker1.   

Abstract

Tolerance to the hemodynamic and antianginal effects of the organic nitrates develops rapidly during therapy. This has been documented with a variety of nitrate preparations and with different routes of administration. Dosing strategies designed to provide therapeutic plasma nitrate concentrations throughout the 24 hours of the day are regularly associated with the development of tolerance. Recent information indicates that dosing schedules providing a nitrate-free period will permit continued efficacy of the organic nitrates without tolerance development. This can be accomplished in several ways. With oral preparations of isosorbide dinitrate, medication can be given 3 times daily, omitting the evening dose. Buccal nitroglycerin is usually given 3 times daily after meals, and this has been shown not to be associated with tolerance. Likewise, preliminary studies suggest that removal of the nitroglycerin patches for a period of several hours each day will prevent the development of tolerance. Much needs to be learned about the nitrate-free period. With oral isosorbide dinitrate, it appears that 12 hours is required, but this could be substantially less with nitroglycerin preparations. It is also possible that several short periods with low nitrate levels each day would suffice. Thus, simply increasing the interval between dosing of oral preparations may provide an adequate, low, nitrate-free period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488098     DOI: 10.1007/bf00133214

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  31 in total

1.  Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

Authors:  U Thadani; S F Hamilton; E Olson; J Anderson; W Voyles; R Prasad; S M Teague
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

2.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

Authors:  M D Winniford; P L Kennedy; P J Wells; L D Hillis
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

3.  Mechanism of tolerance development to organic nitrates.

Authors:  P Needleman; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

4.  Pharmacokinetics of nitroglycerin and long-acting nitrate esters.

Authors:  H L Fung
Journal:  Am J Med       Date:  1983-06-27       Impact factor: 4.965

5.  Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin.

Authors:  J J Dalal; L Yao; J O Parker
Journal:  J Am Coll Cardiol       Date:  1983-07       Impact factor: 24.094

6.  Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.

Authors:  J O Parker; K A VanKoughnett; H L Fung
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

7.  A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction.

Authors:  Y Lis; D Bennett; G Lambert; D Robson
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

8.  Nitrate tolerance: the lack of effect of N-acetylcysteine.

Authors:  J O Parker; B Farrell; K A Lahey; B F Rose
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

9.  Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use.

Authors:  D T Danahy; W S Aronow
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

10.  Nitroglycerin ointment effective for seven hours in severe angina pectoris.

Authors:  R Kala; P Hirvonen; A Gordin; S Sundberg; J Auvinen; P I Halonen
Journal:  Acta Med Scand       Date:  1983
View more
  6 in total

1.  Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies.

Authors:  Johannes-Peter Stasch; Cristina Alonso-Alija; Heiner Apeler; Klaus Dembowsky; Achim Feurer; Torsten Minuth; Elisabeth Perzborn; Matthias Schramm; Alexander Straub
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.

Authors:  T Münzel; A Giaid; S Kurz; D J Stewart; D G Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

3.  [Nicorandil: acute hemodynamic effects of 2 different oral doses of a potassium channel opener in patients with coronary heart disease].

Authors:  C Bickel; H J Rupprecht; A Tyrtania; J Rörig; J Meyer
Journal:  Med Klin (Munich)       Date:  1999-02-15

4.  Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies.

Authors:  Johannes-Peter Stasch; Klaus Dembowsky; Elisabeth Perzborn; Elke Stahl; Matthias Schramm
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Reasons for overprescription of mononitrates: the paradigm of stable angina pectoris treatment.

Authors:  Mickie Preis; Ronit Peled; Matityhau Lifshitz; Asher Elhayani; Asaf Toker; Haim Reuveni
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

6.  Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.

Authors:  Fernanda B M Priviero; Saiprasad M Zemse; Cleber E Teixeira; R Clinton Webb
Journal:  Am J Hypertens       Date:  2009-02-26       Impact factor: 2.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.